Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of hearing loss
3.2.1.2 Technological advancements
3.2.1.3 Rising awareness and early diagnosis
3.2.1.4 Facilitative government support & improving reimbursement scenario
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of cochlear implants
3.2.2.2 Lack of knowledge regarding hearing loss
3.3 Growth potential analysis
3.4 Pricing analysis, 2023
3.5 Reimbursement scenario
3.6 Regulatory landscape
3.7 Consumer pathway
3.8 Technology landscape
3.9 Policy landscape
3.9.1 Risk management analysis
3.9.2 Research and development
3.9.3 Operations
3.9.4 Marketing and sales
3.9.5 Quality
3.9.6 Intellectual property rights
3.9.7 Regulatory
3.9.8 Information technology
3.9.9 Climate
3.9.10 Financial
3.10 Porter's analysis
3.11 GAP analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn & Units)
5.1 Key trends
5.2 Unilateral implants
5.3 Bilateral implants
Chapter 6 Market Estimates and Forecast, By Patient Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Adult
6.3 Pediatric
Chapter 7 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 ENT clinics
7.4 Ambulatory surgical centers
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn & Units)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Cochlear Ltd
9.2 Envoy Medical
9.3 MED-EL GmbH
9.4 Nurotron Biotechnology Co., LTD
9.5 Sonova Holding AG
